Olympus has scored a win at the FDA, with the agency giving the green light for the Spiration valve system (SVS) to treat severe emphysema, a progressive form of chronic obstructive pulmonary disease (COPD). Word of the approval comes months after another company scored an FDA nod for its severe emphysema treatment to serve as an alternative to invasive lung surgery.